FDA Warning Letter — Aspire Pharmaceuticals, Inc.
The FDA took a Warning Letter action against Aspire Pharmaceuticals, Inc. on November 23, 2022 (Somerset, NJ). The action was issued by CFSAN and concerns food/cosmetics products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Aspire Pharmaceuticals, Inc.
- Date
- November 23, 2022
- Fiscal Year
- 2023
- Product Type
- Food/Cosmetics
- Center
- CFSAN
- Location
- Somerset, NJ (United States)